Dynavax Technologies
DVAX
#5492
Rank
A$1.93 B
Marketcap
A$16.50
Share price
-0.09%
Change (1 day)
-17.67%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$56.72 Million, an increase over its 2023 earnings that were of A$3.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-203.57%
2024 A$56.72 M1475.31%
2023 A$3.6 M-99.2%
2022 A$0.45 B238.78%
2021 A$0.13 B-257.89%
2020 -A$84.64 Million-58.58%
2019 -A$0.21 Billion-9.32%
2018 -A$0.23 Billion60.44%
2017 -A$0.15 Billion-15.8%
2016 -A$0.17 Billion4.22%
2015 -A$0.17 Billion16.54%
2014 -A$0.14 Billion37.09%
2013 -A$0.11 Billion
2010 -A$71.7 Million214.85%
2009 -A$22.78 Million-37.33%
2008 -A$36.34 Million-66.07%
2007 -A$0.11 Billion16.92%
2006 -A$91.61 Million170.36%
2005 -A$33.89 Million33.39%
2004 -A$25.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
A$31.13 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.86 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.78 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.89 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.72 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$14.04 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$17.85 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.66 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$12.42 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA